Physician

Mario R. Del Cid, MD

According to 2025 Medicare claims, Mario Cid, MD (NPI: 1407037872) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 33021-6850.

Cid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 13,845 HCPCS/CPT codes, and received $1,374,458 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 386 prescription claims across 134 beneficiaries totaling $22,796 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 29 records totaling $41,652. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $114,781 to $22,796. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$873K$1.7M2015 Medicare payment: $1,313,920 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,440,142 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,282,183 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,593,705 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,576,740 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,647,088 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,746,213 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,532,600 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,541,578 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,374,458 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155767,124$1,313,920
20166608,059$1,440,142
20176757,451$1,282,183
20188108,753$1,593,705
20197978,815$1,576,740
20206708,301$1,647,088
20216928,415$1,746,213
20225687,255$1,532,600
202354611,447$1,541,578
202450513,845$1,374,458

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$152K$304K2015 Drug cost: $114,781 (USD; Tot_Drug_Cst)2016 Drug cost: $126,155 (USD; Tot_Drug_Cst)2017 Drug cost: $121,491 (USD; Tot_Drug_Cst)2018 Drug cost: $160,184 (USD; Tot_Drug_Cst)2019 Drug cost: $214,954 (USD; Tot_Drug_Cst)2020 Drug cost: $213,401 (USD; Tot_Drug_Cst)2021 Drug cost: $303,713 (USD; Tot_Drug_Cst)2022 Drug cost: $89,500 (USD; Tot_Drug_Cst)2023 Drug cost: $43,202 (USD; Tot_Drug_Cst)2024 Drug cost: $22,796 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015184666$114,781
2016186551$126,155
2017164517$121,491
2018154468$160,184
2019163446$214,954
2020141451$213,401
2021191560$303,713
2022149388$89,500
2023148415$43,202
2024134386$22,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye191738$104
92014Established patient complete exam of visual system4391,087$99
92134Imaging of retina4541,122$33
92250Photography of the retina113122$27
92201Extended exam of the back part of the eye with retinal drawing208246$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1005,750$6,237
Bromfenac SodiumBromfenac Sodium401,260$5,277
Ketorolac TromethamineKetorolac Tromethamine583,287$1,362
Brimonidine TartrateBrimonidine Tartrate231,508$756
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim471,975$424

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.24$12,215Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.5$29,437Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mario R. Del Cid, MD?

Tedicare shows public-source Medicare data for Mario R. Del Cid, MD (NPI 1407037872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mario R. Del Cid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mario R. Del Cid, MD?

Mario R. Del Cid, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Mario R. Del Cid, MD have Open Payments data?

Mario R. Del Cid, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.